Paulding Ohio Hospital Deploys BIO-key’s PortalGuard® Cloud Platform to Manage Identity-Bound Biometric Authentication for Epic Hyperdrive
12 Julho 2023 - 9:02AM
BIO-key International, Inc. (NASDAQ: BKYI), an innovative provider
of workforce and customer identity and access management (IAM)
solutions featuring Identity-Bound Biometrics (IBB), announced that
longstanding customer Paulding County Hospital (PCH) is deploying
BIO-key’s PortalGuard® Identity-as-a-Service (IDaaS) cloud platform
to leverage its existing investment in BIO-key’s biometric
authentication solution as it migrates to Epic Hyperdrive. The new
browser-based Epic Hyperdrive electronic health records system is
replacing Epic’s legacy Hyperspace application.
Recognizing the importance of efficient and
secure access to critical healthcare applications, PCH is deploying
PortalGuard IDaaS in conjunction with Epic Hyperdrive to extend its
use of BIO-key’s biometric authentication capabilities to ensure
strict compliance with patient privacy regulations such as HIPAA
(the Health Insurance Portability and Accountability Act) in the
cloud. By deploying PortalGuard with BIO-key biometrics, PCH avoids
system-wide user re-enrollment or the adoption of more cumbersome,
expensive, or less secure shared authentication solutions. In
addition, PortalGuard’s SAML-based Single Sign-On (SSO) Identity
Provider capabilities will deliver secure, streamlined,
multi-factor authentication for other hospital software
applications. Driving the PCH project timeline is the Epic
requirement that their customers migrate to Hyperdrive by the
November 2023 release deadline.
"Implementing PortalGuard SAML SSO with their
mission-critical application Epic Hyperdrive allows PCH to
streamline their workflows, reduce administrative burdens, and
ensure secure access to patient information with IBB,” said Mark
Cochran, President of BIO-key – PortalGuard. “Where security and
efficiency are paramount, healthcare organizations face the
challenge of providing convenient and reliable access to necessary
systems while ensuring data privacy and regulatory compliance. Our
IBB solution is revolutionizing biometric authentication in
healthcare, providing organizations with flexible, secure, and
cost-effective access management solutions by reducing or
eliminating reliance on expensive tokens or card-based systems
while also maintaining the highest levels of security.
About BIO-key International,
Inc. (www.BIO-key.com)BIO-key is revolutionizing
authentication and cybersecurity with biometric-centric,
multi-factor identity and access management (IAM) software managing
millions of users. Its cloud-based PortalGuard IAM solution
provides cost-effective, easy-to-deploy, convenient, and secure
access to devices, information, applications, and high-value
transactions. BIO-key's patented software and hardware solutions,
with industry-leading Identity-Bound Biometric (IBB) capabilities,
enable large-scale Identity-as-a-Service (IDaaS) solutions, as well
as customized on-premises solutions.
BIO-key Safe Harbor
StatementAll statements contained in this press release
other than statements of historical facts are "forward-looking
statements" as defined in the Private Securities Litigation Reform
Act of 1995 (the "Act"). The words "estimate," "project,"
"intends," "expects," "anticipates," "believes" and similar
expressions are intended to identify forward-looking statements.
Such forward-looking statements are made based on management's
beliefs, as well as assumptions made by, and information currently
available to, management pursuant to the "safe-harbor" provisions
of the Act. These statements are not guarantees of future
performance or events and are subject to risks and uncertainties
that may cause actual results to differ materially from those
included within or implied by such forward-looking statements.
These risks and uncertainties include, without limitation, our
history of losses and limited revenue; our ability to raise
additional capital; our ability to protect our intellectual
property; changes in business conditions; changes in our sales
strategy and product development plans; changes in the marketplace;
continued services of our executive management team; security
breaches; competition in the biometric technology industry; market
acceptance of biometric products generally and our products under
development; our ability to execute and deliver on contracts in
Africa; our ability to expand into Asia, Africa and other foreign
markets; our ability to integrate the operations and personnel of
Swivel Secure into our business; fluctuations in foreign currency
exchange rates; delays in the development of products and
statements of assumption underlying any of the foregoing as well as
other factors set forth under the caption "Risk Factors" in our
Annual Report on Form 10-K for the year ended December 31, 2022 and
other filings with the Securities and Exchange Commission. Readers
are cautioned not to place undue reliance on these forward-looking
statements, which speak only as of the date made. Except as
required by law, we undertake no obligation to disclose any
revision to these forward-looking statements whether as a result of
new information, future events, or otherwise.
Engage with BIO-key: |
Facebook – Corporate: |
|
|
|
https://www.facebook.com/BIOkeyInternational/ |
LinkedIn – Corporate: |
|
|
|
https://www.linkedin.com/company/bio-key-international |
Twitter – Corporate: |
|
|
|
@BIOkeyIntl |
Twitter – Investors: |
|
|
|
@BIO_keyIR |
StockTwits: |
|
|
|
BIO_keyIR |
|
|
|
|
|
Investor Contacts: |
|
|
|
|
William Jones, David Collins |
|
|
|
|
Catalyst IR |
|
|
|
|
BKYI@catalyst-ir.com |
|
|
|
|
212-924-9800 |
|
|
|
|
BIO key (NASDAQ:BKYI)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
BIO key (NASDAQ:BKYI)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024